Triple

T16861159
Position Surface form Disambiguated ID Type / Status
Subject Office of Compliance and Biologics Quality E409912 entity
Predicate parentOrganization P254 FINISHED
Object Center for Biologics Evaluation and Research E86214 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Biologics Evaluation and Research | Statement: [Office of Compliance and Biologics Quality, parentOrganization, Center for Biologics Evaluation and Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Center for Biologics Evaluation and Research
Context triple: [Office of Compliance and Biologics Quality, parentOrganization, Center for Biologics Evaluation and Research]
  • A. Center for Biologics Evaluation and Research chosen
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • B. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • C. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • D. Office of Compliance and Biologics Quality
    The Office of Compliance and Biologics Quality is a division within the FDA’s biologics center responsible for ensuring the safety, quality, and regulatory compliance of biological products such as vaccines, blood, and cellular therapies.
  • E. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d88395e6c88190b22730f335107c14 completed April 10, 2026, 4:59 a.m.
NER Named-entity recognition batch_69e3b5036e6c8190a3b9e525a34da2e1 completed April 18, 2026, 4:44 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00cfc531c881908a33de8b491842ca completed May 10, 2026, 6:34 p.m.
Created at: April 10, 2026, 5:24 a.m.